Cajal Neuroscience, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Cajal Neuroscience, Inc. - overview
Established
2020
Location
Seattle, WA, US
Primary Industry
Biotechnology
About
Based in Washington, US, and founded in 2020 by its CSO, Ian Peikon, and COO, Andrew Dervan, Cajal Neuroscience, Inc. , operates as a drug discovery company that offers therapeutic solutions for neurodegeneration. In November 2022, Cajal Neuroscience, Inc. , raised USD 96 million in Series A funding, co-led by investors Lux Capital and The Column Group, with participation from other investors, including Alexandria Venture Investments, Bristol-Myers Squibb Company, Dolby Family Ventures, Evotec SE, and Two Sigma Ventures.
As of 2022, the company is led by its CEO, Ignacio Munoz-Sanjuan. The company offers various neurodegeneration solutions that include integrating human genetics, functional genomics, and advanced microscopy to discover novel targets and therapeutics. The company also provides a light-sheet microscopy platform that uses 3D imaging to evaluate complex spatial phenotypes like selective vulnerability or the spread of pathology.
Current Investors
Alexandria Venture Investments, The Column Group, Two Sigma Investments
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Pharmaceutical Research & Development
Website
www.cajalneuro.com
Verticals
HealthTech
Company Stage
Series A
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.